Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
about
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D LigandReviving virus based cancer vaccines by using cytomegalovirus vectors expressing modified tumor antigens.Viral Persistence Induces Antibody Inflation without Altering Antibody AvidityCytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells.Multivalent and Multipathogen Viral Vector Vaccines.Immune Protection by a Cytomegalovirus Vaccine Vector Expressing a Single Low-Avidity Epitope.Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.Combining Adoptive Cell Therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid Skin Tumors.Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.Listeria Monocytogenes: A Model Pathogen Continues to Refine Our Knowledge of the CD8 T Cell Response.The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer
P2860
Q36210368-BF515DC2-EDB7-477C-9A81-0446D979101EQ36597476-06FB006E-C77A-4CF8-A62A-1A6A5281E01DQ36811912-06C9D3C4-4B25-40E8-A540-B578DA70BFFCQ38703382-1512F1A3-C7FD-418A-B908-3144963DF6D4Q38726244-D5E41189-E582-46C8-B62A-EB2995E86261Q38830323-363AC217-7179-408C-9EB6-DF8B51710AE6Q40097692-49881050-BBA3-414E-83AB-24017563364EQ40176792-F21FE92B-6FE7-4F70-8BAF-3E0F23D62F05Q40607907-A617152B-3BEE-4ECA-9F14-E7C1B061B4AAQ49364249-378390B9-73FC-4AE6-B9F6-638169AA4EF3Q55408876-41E76F98-47F1-4450-8B87-9B9DAA6D4256Q55645457-005DD449-368F-45F6-B0C5-481F9B3F6A6EQ58484770-51B2E14C-A71F-40A8-903E-523D079FA55F
P2860
Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cytomegalovirus-Based Vaccine ...... d Protects Mice from Melanoma.
@en
type
label
Cytomegalovirus-Based Vaccine ...... d Protects Mice from Melanoma.
@en
prefLabel
Cytomegalovirus-Based Vaccine ...... d Protects Mice from Melanoma.
@en
P2093
P1476
Cytomegalovirus-Based Vaccine ...... d Protects Mice from Melanoma.
@en
P2093
Barbara Adler
Henry M Smilowitz
Huakang Huang
Jeremy M Grenier
Kamal M Khanna
Oriana A Perez
Zhijuan Qiu
P304
P356
10.1158/2326-6066.CIR-14-0044
P577
2015-01-29T00:00:00Z